JDRF-AUTHORED PAPER SHOWS PATHWAY TO ACCELERATE DISEASE-MODIFYING THERAPIES FOR PEOPLE WITH TYPE 1 DIABETES

NEW YORK, NY -- The following information was released by the Juvenile Diabetes Research Foundation International (JDRF): C-peptide, a biomarker that indicates insulin production, is a validated surrogate endpoint in [...]